
21 Jan Bayer Healthcare
Jason Dowd, Ph.D., Global Lead Cell Therapy Platform Process
Whippany, NJ
(OTCMKTS: BAYRY)
At Bayer, we are committed to advancing the industrialization of cell therapy manufacturing through innovative platform technologies, embodying our mission of “health for all, hunger for none.” By harnessing cutting-edge advancements in bioprocessing, automation, and data analytics, we aim to streamline the production of cell therapies, ensuring scalability and accessibility for patients worldwide. Our approach not only enhances the efficiency and consistency of manufacturing processes but also aligns with our vision of delivering transformative therapies that address unmet medical needs. At the Alliance of Regenerative Medicine Meeting on the Med in 2025, we will showcase our pioneering efforts in establishing robust, sustainable manufacturing solutions that empower healthcare systems and improve patient outcomes. Together, we can redefine the future of regenerative medicine and contribute to a healthier, more equitable world.